WallStreetZenWallStreetZen

NASDAQ: CGTX
Cognition Therapeutics Inc Earnings & Revenue

OverviewForecastEarnings
DividendOwnership

CGTX earnings and revenue history

Current Revenue
$0.0
Current Earnings
-$25.8M
Current Profit Margin
0%

CGTX Return on Equity

Current Company
-83.5%
Current Industry
-63.5%
Current Market
188%
CGTX's Return on Equity (-83.5%)... subscribe to Premium to read more.
High Return on Equity Performance

Be the first to know when CGTX announces earnings.

CGTX Return on Assets

Current Company
-63.1%
Current Industry
2.9%
CGTX is generating lower Return... subscribe to Premium to read more.
Above Average Return on Assets Performance

CGTX Return on Capital Employed

Current Company
-103.07%
Current Industry
19.5%
CGTX has gotten more efficient... subscribe to Premium to read more.
Increasing Return on Capital Employed Performance

CGTX vs Biotech Stocks

TickerRevenueEBITDAEarningsY/Y RevenueY/Y Earnings
CGTX$0.00-$25.51M-$25.79MN/AN/A
ATHA$0.00-$116.49M-$117.67MN/AN/A
VTVT$0.00-$20.15M-$20.25M-100.00%N/A
MRNS$30.99M-$125.31M-$141.41M+257.32%N/A
SPRO$103.78M$25.77M$22.81M+92.11%N/A
View Top Biotech Stocks

CGTX earnings dates

Next earnings date
May 4, 2024

Cognition Therapeutics Earnings & Revenue FAQ

What were CGTX's earnings last quarter?

On Invalid Date, Cognition Therapeutics (NASDAQ: CGTX) reported Q4 2023 earnings per share (EPS) of -$0.27, up 35% year over year. Total Cognition Therapeutics earnings for the quarter were -$8.14 million. In the same quarter last year, Cognition Therapeutics's earnings per share (EPS) was -$0.20.

If you're new to stock investing, here's how to buy Cognition Therapeutics stock.

What was CGTX's earnings growth in the past year?

As of Q2 2024, Cognition Therapeutics's earnings has grown year over year. Cognition Therapeutics's earnings in the past year totalled -$25.79 million.

What is CGTX's earnings date?

Cognition Therapeutics's earnings date is Invalid Date. Add CGTX to your watchlist to be reminded of CGTX's next earnings announcement.

What was CGTX's revenue last quarter?

On Invalid Date, Cognition Therapeutics (NASDAQ: CGTX) reported Q4 2023 revenue of $0.00 up N/A year over year. In the same quarter last year, Cognition Therapeutics's revenue was $0.00.

What was CGTX's revenue growth in the past year?

As of Q2 2024, Cognition Therapeutics's revenue has grown null year over year. Cognition Therapeutics's revenue in the past year totalled $0.00.
©2024 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.